다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Ultragenyx Pharmaceutical Inc (RARE)
Ultragenyx Pharmaceutical Inc (RARE) 뉴스

RARE

Ultragenyx Pharmaceutical (RARE)

Ultragenyx Pharmaceutical Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:RARE

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/07/18	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/07/18	05:05	GlobeNewswire Inc.	Ultragenyx Announces Successful End-of-Phase 2 Meeting with FDA for GTX-102 Angelman Syndrome Program	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/07/13	05:04	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/21	05:30	GlobeNewswire Inc.	Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/21	03:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/21	03:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/21	03:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/17	19:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/15	06:11	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/14	09:49	GlobeNewswire Inc.	Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/13	08:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/13	06:20	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/13	06:10	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/13	05:05	GlobeNewswire Inc.	Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/13	05:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/13	05:00	GlobeNewswire Inc.	Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo Syndrome Type A (MPS IIIA)	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/12	06:47	GlobeNewswire Inc.	Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Osteogenesis Imperfecta (OI)	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/11	08:58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/11	06:20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/05	05:05	GlobeNewswire Inc.	Ultragenyx to Participate at Goldman Sachs 45th Annual Global Healthcare Conference	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/05/31	05:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/05/31	05:00	GlobeNewswire Inc.	Ultragenyx Announces Positive Top-Line Results from Phase 3 Study of DTX401 Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/05/18	05:30	GlobeNewswire Inc.	Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/05/08	05:30	GlobeNewswire Inc.	Ultragenyx to Participate at Bank of America’s 2024 Healthcare Conference	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/05/03	05:00	GlobeNewswire Inc.	Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/05/01	05:00	GlobeNewswire Inc.	Ultragenyx Issues 2023 Corporate Responsibility Report, Showcasing Commitment to Improving Equity and Access to Innovation in Rare Disease	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/04/30	21:00	GlobeNewswire Inc.	Ultragenyx Announces Completion of Enrollment in Phase 3 Orbit and Cosmic Studies Evaluating Setrusumab (UX143) for the Treatment of Osteogenesis Imperfecta (OI)	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/04/26	05:30	GlobeNewswire Inc.	Ultragenyx to Host Conference Call for First Quarter 2024 Financial Results and Corporate Update	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/04/20	05:30	GlobeNewswire Inc.	Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/04/15	20:00	GlobeNewswire Inc.	Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment with GTX-102	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc

검색 관련기사 보기:NASDAQ:RARE

1 2 3 4 5 6 7 8 9 10 다음 >>

Deutsche Telekom (QX)

BNP Paribas (QX)

US Dollar vs Sterling

JP Morgan Chase

Financial Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관